Notice of Annual General Meeting

22. Apr 2021 | 2 min read

The 2021 Annual General Meeting of Gentian Diagnostics AS will be held on 4 May
2021 at 10:00 (CEST) at Bjørnåsveien 5, 1596 Moss.

IMPORTANT INFORMATION REGARDING LIMITATION OF PHYSICAL PRESENCE
Due to the COVID 19 pandemic, the board encourages shareholders to not
physically attend the general meeting. Instead, shareholders are encouraged to
authorize the chairperson of the board to vote on their behalf or use the
enclosed proxy form. By using a proxy with voting instructions, the shareholders
will vote on the specific issues without personal attendance.

Physical attendance increases the risk of infection spreading. Gentian
Diagnostics AS wants to contribute to reducing the spread of COVID 19 and we
hope our shareholders will support this by not physically attending the general
meeting.

Please find the notice including appendices enclosed. The document will also be
made available on www.gentian.com.

530794_GDAS Notice AGM 2021

 

  530794_GDAS Notice AGM 2021.pdf

 

You may also read


May 06, 2026 - Ole Sørlie

Gentian Diagnostics: First quarter 2026 report

Moss, 6 May 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics ASA terminates NT-proBNP assay development

Moss, 6 May 2026 Following a comprehensive review of performance data and market dynamics, Gentian..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics: Ex dividend NOK 0.60 today

Moss, 6 May 2026 The shares in Gentian Diagnostics ASA will be traded ex dividend NOK 0.60 as of today. The..